Market Overview

22 Healthcare Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

  • Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) shares moved upwards by 53.7% to $3.72 during Thursday's pre-market session. The market cap seems to be at $10.8 million.
  • Phio Pharmaceuticals, Inc. (NASDAQ: PHIO) shares surged 32.8% to $0.15. The market value of their outstanding shares is at $5.7 million.
  • Celyad, Inc. (NASDAQ: CYAD) stock moved upwards by 13.8% to $12.50.
  • Enlivex Therapeutics, Inc. (NASDAQ: ENLV) stock moved upwards by 10.9% to $9.18. The market cap seems to be at $68.9 million.
  • Ocugen, Inc. (NASDAQ: OCGN) stock increased by 10.3% to $0.32. The market value of their outstanding shares is at $19.7 million.
  • Genprex, Inc. (NASDAQ: GNPX) shares rose 8.3% to $0.38. The market value of their outstanding shares is at $7.9 million.
  • Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) shares moved upwards by 7.5% to $1.57. The market value of their outstanding shares is at $4.6 million.
  • NeuBase Therapeutics, Inc. (NASDAQ: NBSE) shares increased by 5.1% to $6.64. The market cap stands at $85.6 million.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares moved upwards by 4.4% to $23.98. The market cap seems to be at $2.6 billion. The most recent rating by Baird, on November 05, is at Outperform, with a price target of $60.00.
  • Aurora Cannabis, Inc. (NYSE: ACB) shares surged 4.2% to $2.74. The market value of their outstanding shares is at $4.8 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
  • Aphria, Inc. (NYSE: APHA) stock increased by 3.9% to $4.68. The market cap seems to be at $1.6 billion.
  • Canopy Growth, Inc. (NYSE: CGC) stock rose 3.9% to $18.34. The market cap stands at $9.1 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
  • Tilray, Inc. (NASDAQ: TLRY) shares increased by 3.7% to $21.70. The market cap stands at $2.2 billion. The most recent rating by MKM Partners, on November 14, is at Neutral, with a price target of $26.00.
  • Cronos Group, Inc. (NASDAQ: CRON) shares rose 3.4% to $7.10. The market cap seems to be at $3.6 billion. The most recent rating by Bank of America, on November 13, is at Buy, with a price target of $15.00.
  • Karuna Therapeutics, Inc. (NASDAQ: KRTX) shares increased by 2.9% to $112.08. The market value of their outstanding shares is at $325.9 million. The most recent rating by Goldman Sachs, on November 18, is at Buy, with a price target of $109.00.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) stock moved upwards by 2.7% to $7.20. The market value of their outstanding shares is at $173.7 million. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
  • Sanofi, Inc. (NASDAQ: SNY) shares increased by 1.7% to $46.73. According to the most recent rating by Guggenheim, on September 23, the current rating is at Buy.
  • Aravive, Inc. (NASDAQ: ARAV) shares rose 1.1% to $9.75. The market cap stands at $74.4 million.

 

Losers

  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares declined 7.2% to $0.28 during Thursday's pre-market session. The market value of their outstanding shares is at $4.3 million.
  • Amarin Corp, Inc. (NASDAQ: AMRN) stock plummeted 2.3% to $19.80. The market cap stands at $5.8 billion. The most recent rating by Oppenheimer, on November 20, is at Underperform, with a price target of $7.00.
  • CRISPR Therapeutics, Inc. (NASDAQ: CRSP) stock fell 2.1% to $66.00. The market cap stands at $2.2 billion. The most recent rating by Oppenheimer, on November 12, is at Outperform, with a price target of $65.00.
  • Grifols, Inc. (NASDAQ: GRFS) shares decreased by 1.0% to $21.99. According to the most recent rating by Santander, on October 28, the current rating is at Buy.

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

 

Related Articles (AMRN + ACB)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

This Dividend ETF Is Having Its Day

7 Technology Stocks Moving In Thursday's Pre-Market Session